Organon & Co (OGN)
20.40
+0.03
(+0.15%)
USD |
NYSE |
May 09, 10:27
Organon Gross Profit Margin (Quarterly): 59.00% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 59.00% |
December 31, 2023 | 57.26% |
September 30, 2023 | 59.71% |
June 30, 2023 | 60.20% |
March 31, 2023 | 62.29% |
December 31, 2022 | 60.00% |
September 30, 2022 | 64.15% |
June 30, 2022 | 62.90% |
March 31, 2022 | 64.20% |
Date | Value |
---|---|
December 31, 2021 | 62.63% |
September 30, 2021 | 61.94% |
June 30, 2021 | 63.45% |
March 31, 2021 | 60.76% |
December 31, 2020 | 63.67% |
September 30, 2020 | 66.83% |
June 30, 2020 | 69.86% |
March 31, 2020 | 69.78% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
57.26%
Minimum
Dec 2023
69.86%
Maximum
Jun 2020
62.86%
Average
62.63%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
Amgen Inc | 57.03% |
Merck & Co Inc | 77.56% |
Pfizer Inc | 77.29% |
Alnylam Pharmaceuticals Inc | 86.65% |
Moderna Inc | 42.52% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | 9.23% |
Return on Invested Capital | 12.56% |
Profit Margin (Quarterly) | 12.39% |
Operating Margin (Quarterly) | 25.52% |
Return on Net Operating Assets | 11.43% |